A life science company developing innovative technologies for the medical diagnostics and healthcare market. Currently, the Company's most advanced project is the BACTEROMIC system, a fast, automated system for testing bacterial sensitivity to antibiotics (Antibiotic Susceptibility Testing, AST), which offers access to precise information enabling the selection of appropriate antibiotic therapies, combining high efficiency with ease of use. It is also developing two other projects: EDOCERA - a system that will provide rapid diagnosis of stroke and HYBOLIC - a system that is to enable early detection of the risk of metabolic syndrome leading to, among others, insulin resistance and type 2 diabetes, by monitoring the concentration of key biomarkers, including hormones.